The recent Lancet paper (Xie and Al-Aly) is another eye-opener highlighting the increased risk of hyperglycemia related to COVID-19 :
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00044-4/fulltext
Diabetes risk was raised >40% at one year. Vigilant screening for, and close management of, hyperglycemia is warranted and could be incorporated in the guidelines.
CGM can play a useful role in management (Dr. Weinstock):
Time In Range Online Collaborative
------------------------------
Ali Rizvi, MD
UCF College of Medicine
Orlando, FL
------------------------------